Context And Objectives: Chronic myeloid leukemia (CML) requires strict daily compliance with oral medication and regular blood and bone marrow control tests. The objective was to evaluate CML patients' perceptions about the disease, their access to information regarding the diagnosis, monitoring and treatment, adverse effects and associations of these variables with patients' demographics, region and healthcare access.
Design And Setting: Prospective cross-sectional study among CML patients registered with the Brazilian Lymphoma and Leukemia Association (ABRALE).
Purpose: The purpose of this study was to evaluate the quality of life (QOL) of patients receiving treatment by the public health system in Brazil for chronic myeloid leukemia (CML), a disease requiring daily and strict compliance to oral medication and regular blood and bone marrow controls, which are invasive exams.
Methods: Between 2008 and 2010, patients with CML were surveyed by telephone. Quality of life was evaluated by the functional assessment of chronic illness therapy (FACIT) tool.
Objective: To report the main endocrine effects after cancer treatment in children and adolescents and associate them to the disease and its treatment.
Subjects And Methods: Clinical and lab evaluation for endocrinopathy was performed in 320 patients after cancer therapy have been followed for six years.
Results: The most prevalent endocrine late effects in patients were: 32 patients had short stature, nine of them were under growth hormone therapy.
Objective: To assess the vaccination history and the status of vaccine-induced protection from measles and rubella in children after treatment for acute lymphoblastic leukemia.
Methods: Measles and rubella immunological status was assessed by the ELISA technique for 22 children previously treated for acute lymphoblastic leukemia.
Results: From the total of 22 patients, 20 had been given two doses of measles vaccine and 18 had had one dose of rubella vaccine.